Thus, in addition to the greater prevalence of progressive ILD in CVID patients with TACI mutations there was apparently greater resistance to B cell depletive therapy, possibly due to elevated signaling through BAFF-R. This evidence concerns the gene TNFRSF13B and common variable immunodeficiency.